Significant responses to platinum‐based chemotherapy in renal medullary carcinoma
Authors:
- 15 December 2004
- journal article
- case report
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 44 (4) , 407-411
Abstract
Most patients with renal medullary carcinoma (RMC) have advanced disease at presentation and rarely respond to radiation or chemotherapy. We describe two adolescents with metastatic disease who had significant responses to cisplatin or carboplatin in combination with gemcitabine and paclitaxel.Keywords
This publication has 19 references indexed in Scilit:
- Renal Medullary CarcinomaAmerican Journal of Clinical Oncology, 2003
- Renal medullary carcinoma in a six-year-old boy with sickle cell traitPathology and Oncology Research, 2003
- Renal Medullary Carcinoma: A Report of 2 Cases and Review of the LiteratureArchives of Pathology & Laboratory Medicine, 2003
- Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implicationsUrology, 2002
- Combination Paclitaxel, Carboplatin, and Gemcitabine Is an Active Treatment for Advanced Urothelial CancerJournal of Clinical Oncology, 2001
- Phase I-II Study of Paclitaxel, Cisplatin, and Gemcitabine in Advanced Transitional-Cell Carcinoma of the UrotheliumJournal of Clinical Oncology, 2000
- RENAL MEDULLARY CARCINOMA: CAN EARLY DIAGNOSIS LEAD TO LONG-TERM SURVIVAL?Journal of Urology, 2000
- Prolonged Survival of a Patient With Sickle Cell Trait and Metastatic Renal Medullary CarcinomaJournal of Pediatric Hematology/Oncology, 1999
- TNM staging of renal cell carcinomaCancer, 1997
- Renal Medullary Carcinoma The Seventh Sickle Cell NephropathyAmerican Journal of Surgical Pathology, 1995